Harnessing gut microbiota for colorectal cancer therapy: from clinical insights to therapeutic innovations.

In a cohort of 158 melanoma patients receiving ICB, self-reported use of commercially available probiotics was associated with a trend toward reduced response rates and shorter progression-free survival, although differences did not reach statistical significance.

also in 111,027 other papers